Cargando…

Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer

BACKGROUND: The prognostic role of serum alkaline phosphatase (ALP) has been found in several kinds of solid malignant tumor, but has never been extensively discussed in pancreatic cancer, especially through the application of dynamic survival model which incorporates the varying nature of ALP measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yuanyuan, Lu, Jian, Chang, Wei, Chen, Ying, Li, Xiaomei, Li, Dehui, Xu, Chuanzhi, Yang, Haijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686543/
https://www.ncbi.nlm.nih.gov/pubmed/31391026
http://dx.doi.org/10.1186/s12885-019-6004-7
_version_ 1783442591033851904
author Xiao, Yuanyuan
Lu, Jian
Chang, Wei
Chen, Ying
Li, Xiaomei
Li, Dehui
Xu, Chuanzhi
Yang, Haijun
author_facet Xiao, Yuanyuan
Lu, Jian
Chang, Wei
Chen, Ying
Li, Xiaomei
Li, Dehui
Xu, Chuanzhi
Yang, Haijun
author_sort Xiao, Yuanyuan
collection PubMed
description BACKGROUND: The prognostic role of serum alkaline phosphatase (ALP) has been found in several kinds of solid malignant tumor, but has never been extensively discussed in pancreatic cancer, especially through the application of dynamic survival model which incorporates the varying nature of ALP measurements. METHODS: We conducted a retrospective study which successfully collected 551 histopathologically confirmed pancreatic ductal adenocarcinoma (PDAC) patients from a cancer specialized hospital in southwest China. The association between variant ALP which measured during the whole survival period and the overall survival (OS) of PDAC patients was evaluated by using dynamic Anderson-Gill (AG) model. Exhaustive sensitivity analysis was performed by adopting continuous cut-offs of ALP. RESULTS: After adjusted for possible confounding of serum albumin, total bilirubin and leukocyte counts, AG model revealed that, serum ALP during the survival period was nonlinearly associated with the OS of PDAC: for resected patients, compared with those whose ALP results ranged within the first quartile (<P(25)), patients whose ALP measurements belonged to the second (P(25)-P(50)), the third (P(50)-P(75)), and the forth (>P(75)) quartiles were observed 1.14 (95% CI: 0.29–4.56), 3.93 (95% CI: 1.23–12.60), 3.87 (95% CI: 1.32–11.36) folds of death hazard; whereas in un-resected PDAC patients, the hazard ratios (HRs) were 1.15 (95% CI: 0.79–1.68), 1.92 (95% CI: 1.32–2.78), and 1.97 (95% CI: 1.30–2.98), respectively. Sensitivity analysis revealed that, for both resected and un-resected patients, the results of AG model were robust with regard to various cut-offs of ALP, and an increased ALP was in general associated with significantly increased hazard of death. CONCLUSION: Serum ALP during the survival period was significantly associated with the OS of PDAC patients, especially for resected early stage PDAC patients. Future studies with expanded sample size and refined prospective design should be implemented to corroborate our major findings. Besides, the underlying mechanism for this possible hazardous role of ALP should also be investigated.
format Online
Article
Text
id pubmed-6686543
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66865432019-08-12 Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer Xiao, Yuanyuan Lu, Jian Chang, Wei Chen, Ying Li, Xiaomei Li, Dehui Xu, Chuanzhi Yang, Haijun BMC Cancer Research Article BACKGROUND: The prognostic role of serum alkaline phosphatase (ALP) has been found in several kinds of solid malignant tumor, but has never been extensively discussed in pancreatic cancer, especially through the application of dynamic survival model which incorporates the varying nature of ALP measurements. METHODS: We conducted a retrospective study which successfully collected 551 histopathologically confirmed pancreatic ductal adenocarcinoma (PDAC) patients from a cancer specialized hospital in southwest China. The association between variant ALP which measured during the whole survival period and the overall survival (OS) of PDAC patients was evaluated by using dynamic Anderson-Gill (AG) model. Exhaustive sensitivity analysis was performed by adopting continuous cut-offs of ALP. RESULTS: After adjusted for possible confounding of serum albumin, total bilirubin and leukocyte counts, AG model revealed that, serum ALP during the survival period was nonlinearly associated with the OS of PDAC: for resected patients, compared with those whose ALP results ranged within the first quartile (<P(25)), patients whose ALP measurements belonged to the second (P(25)-P(50)), the third (P(50)-P(75)), and the forth (>P(75)) quartiles were observed 1.14 (95% CI: 0.29–4.56), 3.93 (95% CI: 1.23–12.60), 3.87 (95% CI: 1.32–11.36) folds of death hazard; whereas in un-resected PDAC patients, the hazard ratios (HRs) were 1.15 (95% CI: 0.79–1.68), 1.92 (95% CI: 1.32–2.78), and 1.97 (95% CI: 1.30–2.98), respectively. Sensitivity analysis revealed that, for both resected and un-resected patients, the results of AG model were robust with regard to various cut-offs of ALP, and an increased ALP was in general associated with significantly increased hazard of death. CONCLUSION: Serum ALP during the survival period was significantly associated with the OS of PDAC patients, especially for resected early stage PDAC patients. Future studies with expanded sample size and refined prospective design should be implemented to corroborate our major findings. Besides, the underlying mechanism for this possible hazardous role of ALP should also be investigated. BioMed Central 2019-08-07 /pmc/articles/PMC6686543/ /pubmed/31391026 http://dx.doi.org/10.1186/s12885-019-6004-7 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xiao, Yuanyuan
Lu, Jian
Chang, Wei
Chen, Ying
Li, Xiaomei
Li, Dehui
Xu, Chuanzhi
Yang, Haijun
Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title_full Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title_fullStr Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title_full_unstemmed Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title_short Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
title_sort dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686543/
https://www.ncbi.nlm.nih.gov/pubmed/31391026
http://dx.doi.org/10.1186/s12885-019-6004-7
work_keys_str_mv AT xiaoyuanyuan dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT lujian dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT changwei dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT chenying dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT lixiaomei dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT lidehui dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT xuchuanzhi dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer
AT yanghaijun dynamicserumalkalinephosphataseisanindicatorofoverallsurvivalinpancreaticcancer